Viridian Therapeutics, Inc.
VRDN
$19.19
$1.176.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.40% | 3.82% | 50.32% | 140.65% | 70.92% |
| Total Receivables | -- | -- | -- | -86.27% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 49.49% | 52.30% | 131.81% | 31.44% | -13.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -0.50% | 4.85% | 51.80% | 136.96% | 67.95% |
|
|
|||||
| Total Current Assets | -0.50% | 4.85% | 51.80% | 136.96% | 67.95% |
| Net Property, Plant & Equipment | -8.14% | 8.18% | 2.96% | 0.96% | -15.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -23.22% | -11.89% | -17.05% | -32.46% | -44.34% |
| Total Assets | -0.57% | 4.85% | 51.38% | 134.79% | 66.63% |
|
|
|||||
| Total Accounts Payable | 171.27% | 45.22% | -4.29% | 69.69% | -24.03% |
| Total Accrued Expenses | 16.89% | 29.49% | 93.52% | 86.03% | 27.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 158.95% | -26.78% | -39.15% | -28.26% | 332.79% |
| Total Finance Division Other Current Liabilities | -25.77% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Current Liabilities | -25.77% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Liabilities | 43.04% | 29.09% | 79.74% | 77.93% | 28.28% |
|
|
|||||
| Total Current Liabilities | 43.04% | 29.09% | 79.74% | 77.93% | 28.28% |
| Long-Term Debt | -29.36% | 1.76% | 1.87% | 2.62% | 271.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.65% | 110.27% | 104.65% | 67.65% | 15.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.19% | -57.60% | -50.44% | -44.81% | -47.87% |
| Total Liabilities | 19.23% | 18.09% | 46.20% | 42.55% | 58.17% |
|
|
|||||
| Common Stock & APIC | 29.08% | 29.41% | 53.85% | 77.50% | 47.58% |
| Retained Earnings | -40.99% | -39.81% | -37.19% | -39.01% | -37.30% |
| Treasury Stock & Other | 112.71% | 166.76% | -102.96% | 1,556.25% | -213.87% |
| Total Common Equity | -1.01% | 8.56% | 104.99% | 248.85% | 82.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -5.42% | -5.42% | -8.54% | 40.01% | 48.03% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -5.42% | -5.42% | -8.54% | 40.01% | 48.03% |
|
|
|||||
| Total Common Equity | -1.01% | 8.56% | 104.99% | 248.85% | 82.17% |
| Total Preferred Equity | -5.42% | -5.42% | -8.54% | 40.01% | 48.03% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.68% | 3.77% | 51.95% | 149.49% | 67.59% |
|
|
|||||